Investing in startups requires a method before it requires a portfolio

Investing in a startup means financing a business that still has to prove a significant part of its potential. The product may be promising, the market large and the founding team skilled, but turning these conditions into revenue, margins and value for shareholders remains uncertain. To build a portfolio in this area, one must therefore start with a method: which companies can one understand, how much capital can be locked away, and what conditions make the price paid reasonable? Participation in innovation can play a role in wealth, provided it is assessed as an assumption of entrepreneurial risk and not as a shortcut to returns less exposed to market problems.

The first constraint concerns the wealth of the investor

Before the project comes the ability to bear its consequences. Money committed to unlisted stakes may remain unavailable for many years, and the company’s operating success does not guarantee a sale of the shares at the desired time. Capital needed for family expenses, emergencies or already scheduled obligations therefore calls for a separate assessment. There is no universal allocation suitable for everyone: what matters are income, available reserves, other illiquid investments and the possibility of losing in full the amount set aside for these initiatives. Even those who already own a business must consider that they may be adding to the risk of their work an exposure similar in economic terms, rather than true diversification.

The Bank of Italy reminds investors, in its information on crowdfunding, that buying risk capital makes you a shareholder and may lead to the loss of the entire investment. It also stresses that the absence of a market makes it difficult to sell the stake, even when the initiative succeeds. These are features that neither an accessible platform nor a low minimum amount can eliminate. Crowdfunding is one of the possible channels; direct investments, vehicles and funds have different structures. The method must therefore start from what is actually being bought: a stake in the business, an interest in a vehicle, or an exposure managed by third parties, with rights and costs that can change significantly.

Assessing the project means checking how it will reach the next milestone

A useful analysis does not stop at the theoretical size of the market. It must ask which problem is being solved, who is willing to pay and which elements show that demand exists. Actual customers, recurring revenue, the costs needed to acquire and retain clients, and dependence on a few contracts all reveal different aspects of a project’s quality. Reviewing the team concerns skills, incentives and the ability to deal with mistakes, as well as the founders’ track record. When projections promise rapid growth, the point is to understand which assumptions make it possible and what happens if sales or approvals arrive later than expected.

A company’s liquidity is often the most concrete link between the project and survival. One must observe how much cash is being consumed, how much financial runway remains and what result must be achieved before another capital raising. A capital increase is not negative in itself: it can fund development. But it becomes a critical step if the plan depends on future financing already treated as certain. For investors, knowing the next funding need helps decide whether to reserve resources for possible further contributions and understand the effect of raising capital under less favourable conditions. These are questions that a business valuation should make explicit, without pretending to solve them all with a single indicator.

Price and rights can change the outcome of the same project

An interesting business can be a poor investment if the initial valuation already embeds results that are hard to achieve. That is why one must distinguish the quality of the business from the quality of the entry conditions. What matters are the pre- and post-money valuation, the percentage obtained and the possible presence of share or stock classes with different rights. Even the price of the last round, used as a reference, does not necessarily match what a small shareholder could realise by selling. The comparison should be made on the actual instruments subscribed, considering which parties have priority economic rights and what information is available over time.

Dilution makes this difference visible. In a purely illustrative example, a shareholder with 1% falls to 0.75% if, all other conditions being equal and without taking part in the round, new investors obtain 25% of the capital after the transaction. The business may meanwhile be worth more, so dilution and economic loss do not automatically coincide. But one needs to read the bylaws and shareholder agreements: any subscription rights, preferences in the distribution of proceeds and sale rules can affect how much reaches the individual investor. The percentage owned tells only part of the story, especially if convertible instruments or further issuance commitments exist.

Diversifying does not mean choosing a reassuring number of companies

Careful selection remains essential, but it does not allow one to predict in advance how many projects will fail. A portfolio of seven or ten startups does not offer predetermined protection and may still be highly concentrated. Exposures may depend on the same financiers, the same sector or the same availability of capital in the market. Spreading entries over time, considering different stages of development and different markets, and recognising concentrations all help to read the risk; they still do not guarantee a positive outcome. Even delegating selection to a manager requires assessing their experience, strategy, costs and ability to follow the investee companies after the initial investment.

It is also necessary to abandon the idea that the apparent stability of valuations proves total decorrelation from listed markets. A stake that is not traded every day does not show its price changes daily, but it can be affected by the same economic shocks: rising financing costs, weaker demand, and less buyer availability. When a new round or a sale comes, the revision can emerge all at once. The absence of continuous trading changes the way risk is observed, without eliminating the risk itself. This is a distinction to keep in mind even when choosing a patient approach based on analysing the business.

Exit is a possibility to be studied, not a date to be promised

A stock market listing is only one possible exit. An industrial acquisition, a sale to other investors or a transaction on the shares may offer alternatives; they may also never materialise. In the meantime, the investor’s work includes reading reports, checking results against commitments and updating their decisions. If the entry takes place through crowdfunding, the investment information sheet and the protections provided by European regulation help one understand the project, but they do not certify the economic soundness of the transaction. A startup portfolio becomes coherent when selection, contractual terms and the ability to wait are all part of the same strategy. Initial conviction becomes method only if it remains open to the test of facts.